Vericel Corp
NASDAQ:VCEL
Vericel Corp
NASDAQ:VCEL
Price:
49.52 USD
5.5%
Market Closed
Updated:
May 8, 2024
Vericel Corp
Revenue
|
Vericel Corp
Revenue Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vericel Corp
NASDAQ:VCEL
|
Revenue
$197.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
17%
|
CAGR 10-Years
151%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$29.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
19%
|
Vericel Corp
Revenue Breakdown
Breakdown by Geography
Vericel Corp
Vericel Corp
Not Available
Breakdown by Segments
Vericel Corp
Vericel Corp
|
Total Revenue:
197.5m
USD
|
|
Total Maci Implants And Kits:
164.8m
USD
|
|
Epicel:
31.6m
USD
|
|
Maci Implants And Kits:
4.9m
USD
|
|
Biopsy Kits - Direct Bill:
2.1m
USD
|
See Also
What is Vericel Corp's Revenue?
Revenue
197.5m
USD
197.5m
USD
Based on the financial report for Dec 31, 2023, Vericel Corp's Revenue amounts to 197.5m USD.
What is Vericel Corp's Revenue growth rate?
Revenue CAGR 10Y
151%
151%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for Vericel Corp have been 17% over the past three years , 17% over the past five years , and 151% over the past ten years .
You don't have any saved screeners yet
